Affiliation:
1. Faculté de Médecine Lariboisière-Saint-Louis, Laboratoire de Bioingénierie et Biomécanique Ostéo-articulaire, Université Denis-Diderot, Paris, France
Abstract
Abstract
Mesenchymal stem cells (MSCs) hold considerable promise in tissue engineering (TE). However, their poor survival when exogenously administered limits their therapeutic potential. Previous studies from our group demonstrated that lack of glucose (glc) (but not of oxygen) is fatal to human MSCs because it serves as a pro-survival and pro-angiogenic molecule for human MSCs (hMSCs) upon transplantation. However, which energy-providing pathways MSCs use to metabolize glc upon transplantation? Are there alternative energetic nutrients to replace glc? And most importantly, do hMSCs possess significant intracellular glc reserves for ensuring their survival upon transplantation? These remain open questions at the forefront of TE based-therapies. In this study, we established for the first time that the in vivo environment experienced by hMSCs is best reflected by near-anoxia (0.1% O2) rather than hypoxia (1%–5% O2) in vitro. Under these near-anoxia conditions, hMSCs rely almost exclusively on glc through anerobic glycolysis for ATP production and are unable to use either exogenous glutamine, serine, or pyruvate as energy substrates. Most importantly, hMSCs are unable to adapt their metabolism to the lack of exogenous glc, possess a very limited internal stock of glc and virtually no ATP reserves. This lack of downregulation of energy turnover as a function of exogenous glc level results in a rapid depletion of hMSC energy reserves that explains their poor survival rate. These new insights prompt for the development of glc-releasing scaffolds to overcome this roadblock plaguing the field of TE based-therapies.
Publisher
Oxford University Press (OUP)
Subject
Cell Biology,Developmental Biology,Molecular Medicine
Reference38 articles.
1. Mesenchymal stem cells;Caplan;J Orthop Res,1991
2. Stromal stem cells: Marrow-derived osteogenic precursors;Owen;Ciba Found Symp,1988
3. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6;Friedman;J Cell Biochem,2006
4. In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs;Logeart-Avramoglou;Tissue Eng Part C Methods,2009
5. Comparison of survival and osteogenic ability of human mesenchymal stem cells in orthotopic and ectopic sites in mice;Manassero;Tissue Eng Part A,2016
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献